About
Bayer Ag Na (XETRA:BAYN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Apr 15 2026
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
Apr 1 2026
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Mar 31 2026
National Advertising Division Recommends Bayer Modify or Discontinue Certain One A Day Men’s Pre-Conception Health Complete Multivitamin Claims
Mar 31 2026
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential
Financials
Revenue
€45.58 B
Market Cap
€39 B
EPS
-3.68
Dividend Yield
0.27%
Translate